AllStars Hs Cell Death Control siRNA
For siRNA transfection optimization and positive control experiments in human cells
Products
The AllStars Hs Cell Death Control siRNA is intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.
AllStars Hs Cell Death siRNA (5 nmol)
Cat. No. / ID: 1027298
Positive cell death phenotype control, 5 nmol
AllStars Hs Cell Death siRNA (20 nmol)
Cat. No. / ID: 1027299
Positive cell death phenotype control, 20 nmol
Features
- Optimization and positive control experiments made easy
- Valuable control for high-throughput RNAi
- Simple evaluation by light microscopy
- Highly effective for a wide range of cell types
Product Details
AllStars Hs Cell Death Control siRNA is a blend of highly potent siRNAs targeting ubiquitously expressed human genes that are essential for cell survival. Knockdown of these genes induces a high degree of cell death, which is visible by light microscopy. Transfection efficiency can be quickly estimated by simply observing cells by straightforward light microscopy 48–96 hours after transfection of AllStars Hs Cell Death Control siRNA, avoiding the need for any complex or laborious downstream assay. AllStars Hs Cell Death Control siRNA is a useful tool for siRNA transfection optimization and can be used routinely as a positive control.
Performance
Fast and easy detection in a wide range of cell types
The performance of AllStars Hs Cell Death Control siRNA is validated for a wide range of cell types (see table).
| Cell line | Cell type |
| 293 | Human embryonic kidney cells |
| A549 | Human alveolar basal epithelial cells |
| CaCo | Human colonic carcinoma cells |
| HeLa | Human cervical cancer cells |
| HeLa S3 | Human cervical cancer cells |
| HepG2 | Human hepatoma cells |
| Huh7 | Human hepatoma cells |
| MCF-7 | Human breast adenocarcinoma cells |
| MDA-MB-231 | Human breast adenocarcinoma cells |
| ME180 | Human cervical squamous carcinoma cells |
| SW 480 | Human colon adenocarcinoma cells |
| Primary cells | Cell type |
| HUVEC | Primary human umbilical vein endothelial cells |
| NHBE | Primary normal human bronchial epithelial cells |
| NHLF | Primary normal human lung fibroblast cells |
Highly efficient knockdown and cell death
Knockdown efficiency using AllStars Hs Cell Death Control siRNA has been quantified by real-time RT-PCR and is >95% for each target mRNA.
The AllStars Hs Cell Death Control significantly outperforms other commercially available toxic control siRNAs in both the level of cell death induced and in the wide range of cell types in which it has been validated. Consistently high levels of cell death are achieved using AllStars Hs Cell Death Control, ensuring effective control experiments (see figure High level of cell death).
See figures
Principle
Easy transfection optimization
When establishing RNAi in start-up experiments or in a new cell line, multiple transfections should be performed under different conditions to determine the optimal conditions for maximum transfection efficiency. These experiments can be performed using AllStars Hs Cell Death Control siRNA (see figures Easy siRNA transfection optimization and Cell death in primary cells). Transfection conditions that result in the greatest degree of cell death compared with transfection with a nonsilencing control siRNA can be maintained in future experiments.
Reliable high-throughput RNAi
In high-throughput RNAi screens, the use of internal positive controls is essential to ensure that optimal transfection conditions are maintained on every plate of the screen. Positive controls that can be analyzed phenotypically have the advantage of allowing transfection efficiency to be observed immediately. Using AllStars Hs Cell Death Control siRNA on every plate allows rapid and inexpensive estimation of the transfection rate on individual plates.
See figures
Procedure
Using AllStars Hs Cell Death Control siRNA, transfection efficiency can be quickly estimated by simply observing cells by straightforward light microscopy 48–96 hours after transfection, avoiding the need for any complex or laborious downstream assay.
AllStars Hs Cell Death Control siRNA can be ordered in tube format in 1 nmol, 5 nmol, or 20 nmol amounts. This control is also available in 96-well plates and 384-well plates (FlexiPlate siRNA) in 1 nmol, 0.25 nmol, or 0.1 nmol amounts.
Applications
- Start-up RNAi experiments
- Transfection optimization
- High-throughput RNAi
Supporting data and figures
High level of cell death.
[A] SW620 cells or [B] SW480 cells (5 x 103 cells per well in 96-well plates) were transfected with 20 nM of AllStars Hs Cell Death Control siRNA or AllStars Negative Control siRNA or an siRNA targeting PLK (a well-known target for induction of cell death). Untransfected cells and cells treated with transfection reagent only were also analyzed. After 72 hours, cell death was quantified using a CellTiter-Blue assay (Promega). AllStars Hs Cell Death Control siRNA resulted in high levels of cell death in both cell types. (Data kindly provided by Dr. Amanda Hummon and Dr. Thomas Reid, National Cancer Institute, Maryland, U.S.A.)
Specifications
| Features | Specifications |
|---|---|
| Design | Designed using HP OnGuard siRNA design |
| Format | Tube |
| Scale or yield | 5 nmol, 20 nmol |
| Target sequence provided | No |
| Modification | Yes |
| Species | Human |
Resources
Brochures & Guides (2)
Safety Data Sheets (1)
Technical Information (1)
Certificates of Analysis (1)
FAQ
Which controls can I choose for FlexiPlate siRNA?
Do you have FACS or Fluoro-Microscopy data using HiPerFect HTS Reagent for delivery of siRNA?